Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Wood

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
The Journal of Urology|September 18, 2009
Editorial commentDavid P Wood
The Journal of Urology|November 18, 2011
Re: Pathological Stage Review is Indicated in Primary pT1 Bladder CancerDavid P Wood
The Journal of Urology|November 18, 2011
Re: Expression Signature of E2F1 and its Associated Genes Predict Superficial to Invasive Progression of Bladder TumorsDavid P Wood
The Journal of Urology|November 15, 2011
Vascular endothelial growth factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinomaDavid P Wood
The Journal of Urology|February 14, 2012
Re: bacillus Calmette-Guérin osteomyelitis mimicking spinal metastasis from urothelial cell carcinoma of the bladderDavid P Wood
The Journal of Urology|January 13, 2012
Re: readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trialDavid P Wood
The Journal of Urology|April 9, 2013
Re: loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferationDavid P Wood
The Journal of Urology|February 12, 2013
Re: interobserver variability limits exact preoperative staging by computed tomography in bladder cancerDavid P Wood
The Journal of Urology|October 15, 2013
Re: Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance ProgramDavid P Wood
The Journal of Urology|November 12, 2013
Re: A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final resultsDavid P Wood
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
The Journal of Urology|September 18, 2009
Editorial commentDavid P Wood
The Journal of Urology|November 18, 2011
Re: Pathological Stage Review is Indicated in Primary pT1 Bladder CancerDavid P Wood
The Journal of Urology|November 18, 2011
Re: Expression Signature of E2F1 and its Associated Genes Predict Superficial to Invasive Progression of Bladder TumorsDavid P Wood
The Journal of Urology|November 15, 2011
Vascular endothelial growth factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinomaDavid P Wood
The Journal of Urology|February 14, 2012
Re: bacillus Calmette-Guérin osteomyelitis mimicking spinal metastasis from urothelial cell carcinoma of the bladderDavid P Wood
The Journal of Urology|January 13, 2012
Re: readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trialDavid P Wood
The Journal of Urology|April 9, 2013
Re: loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferationDavid P Wood
The Journal of Urology|February 12, 2013
Re: interobserver variability limits exact preoperative staging by computed tomography in bladder cancerDavid P Wood
The Journal of Urology|October 15, 2013
Re: Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance ProgramDavid P Wood
The Journal of Urology|November 12, 2013
Re: A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final resultsDavid P Wood
Pageof 16